-2%
Cefuroxime is a broad-spectrum, β-lactamase–resistant antibiotic that acts by inhibiting bacterial cell wall synthesis, making it effective against both Gram-positive and Gram-negative organisms, including ampicillin- and amoxicillin-resistant strains.
Roxiclav (Cefuroxime)
- Roxiclav is indicated for treating infections caused by susceptible bacteria, including:
- Upper respiratory tract infections – Pharyngitis, tonsillitis (Streptococcus pyogenes)
- Ear infections – Acute otitis media (S. pneumoniae, H. influenzae, M. catarrhalis)
- Sinus infections – Acute bacterial maxillary sinusitis (S. pneumoniae, H. influenzae)
- Lower respiratory tract infections – Pneumonia, bronchitis, and secondary bacterial infections caused by S. pneumoniae, H. influenzae, K. spp., S. aureus, S. pyogenes, or E. coli
- Skin and soft tissue infections – Due to S. aureus or S. pyogenes
- Urinary tract infections – Due to E. coli or K. pneumoniae
- Bone and joint infections – Caused by S. aureus
- Gonorrhoea – Penicillinase and non-penicillinase producing N. gonorrhoeae
- Early Lyme disease – Due to Borrelia burgdorferi
